OPTIMI HEALTH CORP. (8BN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has a cash flow conversion efficiency ratio of -0.127x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-636.99K ≈ $-744.70K USD) by net assets (€5.02 Million ≈ $5.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
OPTIMI HEALTH CORP. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how OPTIMI HEALTH CORP.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 8BN liabilities breakdown for a breakdown of total debt and financial obligations.
OPTIMI HEALTH CORP. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OPTIMI HEALTH CORP. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Canuc Resources Corp
V:CDA
|
-0.866x |
|
Salee Industry Public Company Limited
BK:SALEE
|
0.023x |
|
LL Lucky Games publ AB
ST:LADYLU
|
0.221x |
|
Lion Forest Industries Bhd
KLSE:8486
|
-0.001x |
|
Norwegian Block Exchange AS
OL:NBX
|
-0.050x |
|
Safestore Holdings Plc
LSE:SAFE
|
0.026x |
|
Komputronik S.A.
WAR:KOM
|
-0.008x |
|
DigiCAP Co. Ltd
KQ:197140
|
0.125x |
Annual Cash Flow Conversion Efficiency for OPTIMI HEALTH CORP. (2022–2025)
The table below shows the annual cash flow conversion efficiency of OPTIMI HEALTH CORP. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see OPTIMI HEALTH CORP. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €6.57 Million ≈ $7.68 Million |
€-2.63 Million ≈ $-3.07 Million |
-0.400x | +10.56% |
| 2024-09-30 | €9.58 Million ≈ $11.20 Million |
€-4.28 Million ≈ $-5.01 Million |
-0.447x | -64.02% |
| 2023-09-30 | €13.21 Million ≈ $15.44 Million |
€-3.60 Million ≈ $-4.21 Million |
-0.273x | +4.63% |
| 2022-09-30 | €16.02 Million ≈ $18.73 Million |
€-4.58 Million ≈ $-5.35 Million |
-0.286x | -- |
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of m… Read more